Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults
NCT07805837Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine, Fluzone Trivalent, influenza vaccine (quadrivalent, high-dose) in influenza, sponsored by Korea University Guro Hospital. Started Oct 2025; status: completed.
02
Drugs
influenza vaccineFluzone Trivalentinfluenza vaccine (quadrivalent, high-dose)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07805837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07805837.